Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
One in four hepatitis C patients denied initial approval for drug treatment

This study adds to a growing body of literature on the hepatitis C “cascade of care,” in which attrition occurs at every step from diagnosis, confirmation, linkage to care, and treatment.

Published
28 August 2015
From
Yale News
White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid

The advisory council criticized three types of restrictions. Some states cover the new drugs only for patients who have advanced liver disease. Many states require patients to abstain from the use of alcohol or illicit drugs for up to a year before treatment. And some states will not cover the drugs unless they are prescribed by specialists like gastroenterologists or experts on infectious diseases.

Published
26 August 2015
From
New York Times
Hepatitis C treatment: Back to the warehouse

Like many physicians that specialize in hepatitis C virus (HCV) treatment, I have spent the last few years advising many of my patients with chronic HCV infection to defer treatment and wait for new therapies. Patients, advocacy groups, and physicians closely followed the development of [these new therapies] in eager anticipation of US Food and Drug Administration (FDA) approval and, for most patients, the possibility of a cure of their HCV infection. However, this eager anticipation morphed into uneasy concern as, along with FDA approval, drug pricing was announced.

Published
26 August 2015
From
Clinical Liver Disease
While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

If Washington wants to do something about the public health issues left behind by the opioid abuse epidemic, it might have to start doing something about prescription-drug costs.

Published
19 August 2015
From
National Journal
Hepatitis C patients in England denied lifesaving liver drug

Health experts concerned about decision not to extend Daklinza treatment to patients with genotype 3 strain of virus.

Published
18 August 2015
From
The Observer
Hepatitis C cure associated with significant improvement in liver stiffness in people with HIV and HCV co-infection

A successful response to hepatitis C virus (HCV) therapy is associated with a significant improvement in liver stiffness among people with HIV and HCV co-infection, French investigators report

Published
17 August 2015
By
Michael Carter
How the Heroin Crisis Ushered in a Hepatitis C Epidemic

Meanwhile, high prices and stringent requirements from insurers and Big Pharma are limiting access to effective treatment.

Published
12 August 2015
From
Boston magazine
Cirrhosis and decompensation are common among people with chronic hepatitis C

More than one-quarter of people with chronic hepatitis C at Kaiser-Permanente developed liver cirrhosis over 12 years and 40% of these experienced decompensation – higher rates than

Published
11 August 2015
By
Liz Highleyman
Improving access to, and completion of, hepatitis C treatment

Treating hepatitis C infection is an effective and cost-effective way to substantially reduce prevalence, especially in areas where it is high. Compliance with the new treatment is easier and can be further improved by well-planned support for patients. .

Published
04 August 2015
From
Public Health England
Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Interferon-free treatment using daclatasvir (Daklinza) and sofosbuvir (Sovaldi), with or without ribavirin, was well-tolerated and produced sustained virological response rates of 95-100% for people with HIV and

Published
03 August 2015
By
Liz Highleyman
← First12345...63Next →

Filter by country